Docebo (DCBO) Cash & Equivalents (2019 - 2026)

Docebo (DCBO) has reported Cash & Equivalents for 8 consecutive years, with $45.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash & Equivalents fell 29.21% year-over-year to $45.7 million; the trailing twelve-month figure through Jun 2026 stood at $45.7 million (down 29.21% YoY), and the FY2025 full-year result was $74.0 million, down 19.99% from the prior year.
• Cash & Equivalents declined to $45.7 million in Q2 2026 per DCBO's latest filing, from $63.2 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $216.3 million in Q4 2022 and bottomed at $45.7 million in Q2 2026.
• Historically, Cash & Equivalents has averaged $125.5 million across 5 years, with a median of $87.0 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Cash & Equivalents plunged 66.73% in 2023, then increased 28.62% in 2024.
• Over 5 years, Cash & Equivalents stood at $216.3 million in 2022, then plunged by 66.73% to $72.0 million in 2023, then rose by 28.62% to $92.5 million in 2024, then slipped by 19.99% to $74.0 million in 2025, then tumbled by 38.25% to $45.7 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $45.7 million, $63.2 million, and $74.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.